Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539588 · ClinicalTrials.gov registry record · NA
Trigger Point Dry Needling vs Trigger Point Dry Needling With Intramuscular Electrical Stimulation
A NA study, sponsored by William Beaumont Army Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03539588: Completed NA study, sponsored by William Beaumont Army Medical Center.
NCT03539588 is a NA study that has completed, run by William Beaumont Army Medical Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03539588, a NA study, has completed, sponsored by William Beaumont Army Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
trigger point dry needling with intramuscular electrical stimulation vs trigger point dry needling
Primary Outcome
an 11 point scale on which the participant will grade their pain
Interventions
- DEVICE Electrical Stimulation
- DEVICE trigger point dry needling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2017-11-13 |
| Phase | NA |
What the finished NCT03539588 record still lists
NCT03539588 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Electrical Stimulation is the first listed.
NCT03539588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03539588 about?
NCT03539588 is a clinical study titled "Trigger Point Dry Needling vs Trigger Point Dry Needling With Intramuscular Electrical Stimulation". trigger point dry needling with intramuscular electrical stimulation vs trigger point dry needling
What is the current status of trial NCT03539588?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-04-12. Estimated completion is 2017-11-13.
What interventions are being tested in trial NCT03539588?
The interventions under investigation include: Electrical Stimulation (DEVICE), trigger point dry needling (DEVICE).
Who is sponsoring clinical trial NCT03539588?
This trial is sponsored by William Beaumont Army Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03539588's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI